Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELUW) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to 244.13%.

  • Celularity's EBIT Margin fell 1201300.0% to 244.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 209.78%, marking a year-over-year decrease of 1770700.0%. This contributed to the annual value of 70.75% for FY2024, which is 7736900.0% up from last year.
  • Per Celularity's latest filing, its EBIT Margin stood at 244.13% for Q3 2025, which was down 1201300.0% from 276.57% recorded in Q2 2025.
  • Celularity's 5-year EBIT Margin high stood at 423.47% for Q4 2022, and its period low was 2621.66% during Q3 2023.
  • Moreover, its 5-year median value for EBIT Margin was 244.13% (2025), whereas its average is 624.95%.
  • In the last 5 years, Celularity's EBIT Margin tumbled by -24851200bps in 2023 and then soared by 24976600bps in 2024.
  • Over the past 5 years, Celularity's EBIT Margin (Quarter) stood at 307.89% in 2021, then skyrocketed by 238bps to 423.47% in 2022, then tumbled by -74bps to 109.93% in 2023, then crashed by -1327bps to 1348.84% in 2024, then skyrocketed by 82bps to 244.13% in 2025.
  • Its EBIT Margin stands at 244.13% for Q3 2025, versus 276.57% for Q2 2025 and 91.77% for Q1 2025.